contact us
sort news by author
Alexandra Faulker-Hardy, Andy Peel, Caitlin Wilkinson, Caoimhe McElduff, Charlotte Stockton, David Laws, Edward Jones, Emma Petela, GK Strategy, Harry Shackleton, Ian Perrin, Isabelle Hillson, Jack Sansum, James Page, Jamie Cater, Jennifer Berger, Joe Berkhout, Joe Cormack, Johnny Munro, Louise Allen, Luke Kennedy, Mark Fuller, Martin Summers, Megan Baxter, Ned Lamb, Olivia Rohll, Rebecca Lury, Robin Grainger, Sarah De Rosa, Tim Farazmand, Tim Swabey, Viya Nsumbu,
sort news by category
Insight, Strategy, Impact,
awards, B2G, Bills, Boris, Brexit, business, careers, climate change, commissioning, Communications, Crisis comms, culture, Digital, Due Diligence, Education, Energy, Energy and Environment, Environment, Equality, ESG, EU, europe, Financial Services, General News, GK culture, Government, government affairs, Health, Healthcare, housing, HS2, infrastructure, insight, internship, Investment, Investor, Investor Backed Businesses, Investor Services, investors, Legislation, NHS, No deal, parliament, pharma, Planning, policy, Political Due Diligence, Politics, Pride Month, Private Equity, Public Affairs, Public Relations, Queen's Speech, regulation, sales, Select Committee, Social Care, Strategic Communications, sustainability, Technology, Transport, uk, UK Politics, Waste, women, Workplace,
Artificial Intelligence: UK ‘pharmatech’ industry growth
Artificial Intelligence (AI) has been a mainstay in the public’s vocabulary for several years now. Tech revolutionaries have painted a futuristic and transformed world, if not a dystopian one; but only recently have we started to understand what this means for the ordinary citizen, such how it is transforming consumer healthcare. The ever-faster power of computer processors, the ability to house and...
